Sensei Biotherapeutics
SNSE • NASDAQ • Stock Fundamentals
Sensei Biotherapeutics is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Christopher W. Gerry, with a market cap of $23.9M.
Market Cap$23.9M
Employees28.0
CEOChristopher W. Gerry
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 15, 2026 · 12 days agoQ1 2026
View reportNext EarningsAug 4, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Sensei Biotherapeutics FAQ
Common questions about Sensei Biotherapeutics
Sensei Biotherapeutics (SNSE) has a market capitalization of $23.9M and trades on NASDAQ.
Sensei Biotherapeutics has approximately 28 employees.